Synalloy Reports Strong Third Quarter 2021 Results
Synalloy Corporation (Nasdaq: SYNL) reports strong financial results for Q3 2021. Net sales surged 45% to $86.2 million, driven by robust commodity pricing and high customer demand. Gross profit rose significantly to $18.0 million, yielding a gross margin of 20.9%. Net income rebounded to $8.2 million, compared to a loss of $10.5 million in Q3 2020. Adjusted EBITDA also increased to $14.8 million, reflecting improved operational efficiencies.
The acquisition of DanChem is expected to enhance Synalloy's specialty chemicals division and overall growth.
- Net sales increased 45% to $86.2 million from $59.3 million in Q3 2020.
- Gross profit rose to $18.0 million with a gross margin of 20.9%, up from 8.4% the previous year.
- Net income of $8.2 million compared to a net loss of $10.5 million in Q3 2020.
- Adjusted EBITDA improved to $14.8 million, up from $1.6 million in the same quarter last year.
- Acquisition of DanChem enhances growth potential in specialty chemicals.
- Chemicals segment faced operational challenges due to labor and raw material constraints.
- Sequential and Year-Over-Year Growth in
Third Quarter 2021 Summary
($ in millions, except per share and margin) |
Q3 2021 |
Q2 2021 |
Q3 2020 |
||||||
|
$ |
86.2 |
|
$ |
83.1 |
|
$ |
59.3 |
|
Gross Profit |
$ |
18.0 |
|
$ |
14.1 |
|
$ |
5.0 |
|
Gross Profit Margin |
|
20.9 |
% |
|
17.0 |
% |
|
8.4 |
% |
Net Income (Loss) |
$ |
8.2 |
|
$ |
2.9 |
|
$ |
(10.5 |
) |
Diluted Earnings (Loss) per share |
$ |
0.87 |
|
$ |
0.31 |
|
$ |
(1.16 |
) |
Adjusted EBITDA |
$ |
14.8 |
|
$ |
9.8 |
|
$ |
1.6 |
|
Adjusted EBITDA Margin |
|
17.2 |
% |
|
11.7 |
% |
|
2.8 |
% |
Management Commentary
“The momentum from the first half of the year continued in the third quarter as we experienced profitable growth across both business segments,” said
“Subsequent to the quarter, we announced the acquisition of DanChem, a leading specialty chemicals contract manufacturer, to accelerate product development capabilities and provide entrance into new end-markets and applications. This acquisition brings robust manufacturing capabilities, a highly experienced team and a blue-chip customer base. We believe Synalloy Chemicals is now one of the largest specialty chemical contract manufacturers in the
“The progress we’ve made since I first joined one year ago, including fortifying our management team with proven industry leaders, completing a major acquisition and delivering several consecutive quarters of profitable growth, gives me the utmost confidence in our foundation. Although the macro environment is dynamic and we are keeping a watchful eye on everything from commodity pricing to supply chain constraints, we will continue to make strides in the areas that we can control as we remain focused on delivering profitable growth and driving shareholder value creation.”
Third Quarter 2021 Financial Results
Net sales increased
Gross profit increased significantly to
Net income increased significantly to
Adjusted EBITDA increased significantly to
Segment Results
Metals – Net sales in the third quarter of 2021 increased
Specialty Chemicals – Net sales in the third quarter of 2021 increased
Liquidity
As of
Conference Call
Date:
Time:
Toll-free dial-in number: 1-877-303-6648
International dial-in number: 1-970-315-0443
Conference ID: 5047445
Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Investor Relations at 1-949-574-3860.
The conference call will be broadcast live and available for replay here and via the investor relations section of the company’s website at www.synalloy.com.
About
Forward-Looking Statements
This press release includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government’s response to COVID-19; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs; raw material availability; financial stability of the Company’s customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company’s debt financing arrangements; and other risks detailed from time-to-time in
Non-GAAP Financial Information
Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures.
Adjusted EBITDA is a non-GAAP measure and excludes goodwill impairment, asset impairment, gain on lease modification, interest expense (including change in fair value of interest rate swap), income taxes, depreciation, amortization, stock-based compensation, non-cash lease cost, acquisition costs and other fees, proxy contest costs and recoveries, earn-out adjustments, loss on extinguishment of debt, realized and unrealized (gains) and losses on investments in equity securities, retention costs and restructuring & severance costs from net income.
Management believes that these non-GAAP measures provide additional useful information to allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP.
Condensed Consolidated Balance Sheets ($ in thousands) |
|||||||
|
(Unaudited) |
|
|
||||
|
|
|
|
||||
Assets |
|
|
|
||||
Cash |
$ |
1,174 |
|
|
$ |
236 |
|
Accounts receivable, net of allowance for credit losses of |
44,096 |
|
|
28,183 |
|
||
Inventories, net |
98,334 |
|
|
85,080 |
|
||
Prepaid expenses and other current assets |
8,820 |
|
|
13,384 |
|
||
Total current assets |
152,424 |
|
|
126,883 |
|
||
|
|
|
|
||||
Property, plant and equipment, net |
29,691 |
|
|
35,096 |
|
||
Right-of-use assets, operating leases, net |
30,975 |
|
|
31,769 |
|
||
|
1,355 |
|
|
1,355 |
|
||
Intangible assets, net |
9,385 |
|
|
11,426 |
|
||
Deferred charges, net |
327 |
|
|
455 |
|
||
Total assets |
$ |
224,157 |
|
|
$ |
206,984 |
|
|
|
|
|
||||
Liabilities and Shareholders' Equity |
|
|
|
||||
Accounts payable |
$ |
34,850 |
|
|
$ |
19,732 |
|
Accounts payable - related parties |
2 |
|
|
— |
|
||
Accrued expenses and other current liabilities |
10,144 |
|
|
6,123 |
|
||
Current portion of long-term debt |
1,750 |
|
|
875 |
|
||
Current portion of earn-out liability |
2,249 |
|
|
3,434 |
|
||
Current portion operating lease liabilities |
1,019 |
|
|
867 |
|
||
Current portion of finance lease liabilities |
40 |
|
|
19 |
|
||
Total current liabilities |
50,054 |
|
|
31,050 |
|
||
|
|
|
|
||||
Long-term debt |
47,213 |
|
|
60,495 |
|
||
Long-term portion of earn-out liability |
— |
|
|
287 |
|
||
Long-term portion of operating lease liabilities |
32,191 |
|
|
32,771 |
|
||
Long-term portion of finance lease liabilities |
46 |
|
|
37 |
|
||
Deferred income taxes |
1,342 |
|
|
1,957 |
|
||
Other long-term liabilities |
84 |
|
|
92 |
|
||
Shareholders' equity |
93,227 |
|
|
80,295 |
|
||
Total liabilities and shareholders' equity |
$ |
224,157 |
|
|
$ |
206,984 |
|
Note: The condensed consolidated balance sheet at
Condensed Consolidated Statement of Operations - Comparative Analysis (Unaudited) ($ in thousands, except per share data) |
||||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Net sales |
|
|
|
|
|
|
|
|||||||||
|
Metals Segment |
$ |
70,127 |
|
|
$ |
47,079 |
|
|
$ |
193,438 |
|
|
$ |
159,761 |
|
|
Specialty Chemicals Segment |
16,055 |
|
|
12,187 |
|
|
45,609 |
|
|
40,338 |
|
||||
|
|
$ |
86,182 |
|
|
$ |
59,266 |
|
|
$ |
239,047 |
|
|
$ |
200,099 |
|
Operating income (loss) |
|
|
|
|
|
|
||||||||||
|
Metals Segment |
$ |
11,711 |
|
|
$ |
(11,563) |
|
|
$ |
21,793 |
|
|
$ |
(19,784) |
|
|
Specialty Chemicals Segment |
1,356 |
|
|
1,061 |
|
|
1,999 |
|
|
3,508 |
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Unallocated expense (income) |
|
|
|
|
|
|
|
|||||||||
|
Corporate |
2,009 |
|
|
1,526 |
|
|
5,138 |
|
|
5,132 |
|
||||
|
Acquisition costs and other |
201 |
|
|
656 |
|
|
201 |
|
|
803 |
|
||||
|
Proxy contest costs and recoveries |
— |
|
|
207 |
|
|
168 |
|
|
3,105 |
|
||||
|
Earn-out adjustments |
160 |
|
|
(146) |
|
|
1,430 |
|
|
(969) |
|
||||
|
Gain on lease modification |
— |
|
|
(171) |
|
|
— |
|
|
(171) |
|
||||
|
Operating income (loss) |
10,697 |
|
|
(12,574) |
|
|
16,855 |
|
|
(24,176) |
|
||||
|
Interest expense |
329 |
|
|
452 |
|
|
1,068 |
|
|
1,703 |
|
||||
|
Loss on extinguishment of debt |
— |
|
|
— |
|
|
223 |
|
|
— |
|
||||
|
Change in fair value of interest rate swap |
— |
|
|
(16) |
|
|
(2) |
|
|
65 |
|
||||
|
Other, net |
(10) |
|
|
59 |
|
|
152 |
|
|
(1,244) |
|
||||
Income (loss) before income taxes |
10,378 |
|
|
(13,069) |
|
|
15,414 |
|
|
(24,700) |
|
|||||
|
Income tax provision (benefit) |
2,179 |
|
|
(2,530) |
|
|
3,235 |
|
|
(6,026) |
|
||||
Net income (loss) |
$ |
8,199 |
|
|
$ |
(10,539) |
|
|
$ |
12,179 |
|
|
$ |
(18,674) |
|
|
|
|
|
|
|
|
|
|
|
||||||||
Net income (loss) per common share |
|
|
|
|
|
|
|
|||||||||
|
Basic |
$ |
0.88 |
|
|
$ |
(1.16) |
|
|
$ |
1.32 |
|
|
$ |
(2.06) |
|
|
Diluted |
$ |
0.87 |
|
|
$ |
(1.16) |
|
|
$ |
1.30 |
|
|
$ |
(2.06) |
|
|
|
|
|
|
|
|
|
|
||||||||
Average shares outstanding |
|
|
|
|
|
|
|
|||||||||
|
Basic |
9,287 |
|
|
9,105 |
|
|
9,237 |
|
|
9,079 |
|
||||
|
Diluted |
9,403 |
|
|
9,105 |
|
|
9,348 |
|
|
9,079 |
|
||||
|
|
|
|
|
|
|
|
|
||||||||
Other data: |
|
|
|
|
|
|
|
|||||||||
|
Adjusted EBITDA (1) |
$ |
14,808 |
|
|
$ |
1,640 |
|
|
$ |
29,447 |
|
|
$ |
6,230 |
|
(1) The term Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is included in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company includes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense (including change in fair value of interest rate swap), income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, acquisition costs and other fees, loss on extinguishment of debt, proxy contest costs and recoveries, earn-out adjustments, realized and unrealized (gains) and losses on investments in equity securities and other investments, stock-based compensation, non-cash lease expense, retention costs and restructuring & severance costs from net income. For a reconciliation of this non-GAAP measure to the most comparable GAAP equivalent, refer to the Reconciliation of Net Income (Loss) to Adjusted EBITDA.
Consolidated Statement of Cash Flows (Unaudited) ($ in thousands) |
|||||||
|
Nine Months Ended |
||||||
2021 |
|
2020 |
|||||
Operating activities |
|
|
|
||||
Net income (loss) |
$ |
12,179 |
|
|
$ |
(18,674) |
|
Adjustments to reconcile net income (loss) to net cash provided by operating activities: |
|
|
|
||||
Depreciation expense |
5,459 |
|
|
5,752 |
|
||
Amortization expense |
2,041 |
|
|
2,324 |
|
||
Amortization of debt issuance costs |
71 |
|
|
129 |
|
||
Asset impairments |
233 |
|
|
6,079 |
|
||
|
— |
|
|
10,748 |
|
||
Loss on extinguishment of debt |
223 |
|
|
— |
|
||
Unrealized gain on equity securities |
— |
|
|
(208) |
|
||
Deferred income taxes |
(615) |
|
|
(2,116) |
|
||
Proceeds from business interruption insurance |
— |
|
|
1,040 |
|
||
Loss on sale of equity securities |
— |
|
|
38 |
|
||
Earn-out adjustments |
1,430 |
|
|
(969) |
|
||
Payments of earn-out liabilities in excess of acquisition date fair value |
(11) |
|
|
(292) |
|
||
(Reduction of) provision for losses on accounts receivable |
(388) |
|
|
53 |
|
||
Provision for losses on inventories |
2,286 |
|
|
874 |
|
||
(Gain) loss on disposal of property, plant and equipment |
(580) |
|
|
237 |
|
||
Non-cash lease expense |
373 |
|
|
385 |
|
||
Non-cash lease termination loss |
5 |
|
|
24 |
|
||
Gain on lease modification |
— |
|
|
(171) |
|
||
Change in fair value of interest rate swap |
(2) |
|
|
65 |
|
||
Issuance of treasury stock for director fees |
58 |
|
|
405 |
|
||
Stock-based compensation expense |
695 |
|
|
1,036 |
|
||
Changes in operating assets and liabilities: |
|
|
|
||||
Accounts receivable |
(15,525) |
|
|
1,438 |
|
||
Inventories |
(15,539) |
|
|
4,593 |
|
||
Other assets and liabilities |
(1,443) |
|
|
(1,902) |
|
||
Accounts payable |
15,118 |
|
|
(1,636) |
|
||
Accounts payable - related parties |
2 |
|
|
— |
|
||
Accrued expenses |
3,272 |
|
|
681 |
|
||
Accrued income taxes |
6,844 |
|
|
(3,963) |
|
||
Net cash provided by operating activities |
16,186 |
|
|
5,970 |
|
||
Investing activities |
|
|
|
||||
Purchases of property, plant and equipment |
(761) |
|
|
(2,824) |
|
||
Proceeds from disposal of property, plant and equipment |
1,054 |
|
|
102 |
|
||
Proceeds from sale of equity securities |
— |
|
|
4,430 |
|
||
Net cash provided by investing activities |
293 |
|
|
1,708 |
|
||
Financing activities |
|
|
|
||||
Borrowings from long-term debt |
41,648 |
|
|
— |
|
||
Payments on long-term debt |
(54,056) |
|
|
(3,000) |
|
||
Payments on BB&T line of credit |
— |
|
|
(1,210) |
|
||
Principal payments on finance lease obligations |
(31) |
|
|
(101) |
|
||
Payments for finance lease terminations |
— |
|
|
(204) |
|
||
Payments on earn-out liabilities |
(2,891) |
|
|
(2,939) |
|
||
Payments for termination of interest rate swap |
(46) |
|
|
— |
|
||
Repurchase of common stock |
— |
|
|
(635) |
|
||
Payments for deferred financing costs |
(165) |
|
|
(52) |
|
||
Net cash used in financing activities |
(15,541) |
|
|
(8,141) |
|
||
Increase (decrease) in cash and cash equivalents |
938 |
|
|
(463) |
|
||
Cash and cash equivalents, beginning of period |
236 |
|
|
626 |
|
||
Cash and cash equivalents, end of period |
$ |
1,174 |
|
|
$ |
163 |
|
Non-GAAP Financial Measures Reconciliation Reconciliation of Net Income (Loss) to Adjusted EBITDA (Unaudited) ($ in thousands) |
||||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
|||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
|||||||||
Consolidated |
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ |
8,199 |
|
|
$ |
(10,539) |
|
|
$ |
12,179 |
|
|
$ |
(18,674) |
|
|
Adjustments: |
|
|
|
|
|
|
|
|||||||||
|
Interest expense |
329 |
|
|
452 |
|
|
1,068 |
|
|
1,703 |
|
||||
|
Change in fair value of interest rate swap |
— |
|
|
(16) |
|
|
(2) |
|
|
65 |
|
||||
|
Income taxes |
2,179 |
|
|
(2,530) |
|
|
3,235 |
|
|
(6,026) |
|
||||
|
Depreciation |
1,868 |
|
|
1,805 |
|
|
5,459 |
|
|
5,752 |
|
||||
|
Amortization |
680 |
|
|
705 |
|
|
2,041 |
|
|
2,324 |
|
||||
EBITDA |
13,255 |
|
|
(10,123) |
|
|
23,980 |
|
|
(14,856) |
|
|||||
|
Acquisition costs and other |
201 |
|
|
656 |
|
|
201 |
|
|
807 |
|
||||
|
Proxy contest costs and recoveries (1) |
— |
|
|
207 |
|
|
168 |
|
|
3,105 |
|
||||
|
Loss on extinguishment of debt |
— |
|
|
— |
|
|
223 |
|
|
— |
|
||||
|
Earn-out adjustments |
160 |
|
|
(146) |
|
|
1,430 |
|
|
(969) |
|
||||
|
Loss (gain) on investment in equity securities and other investments |
— |
|
|
69 |
|
|
363 |
|
|
(170) |
|
||||
|
Asset impairments |
— |
|
|
— |
|
|
233 |
|
|
6,079 |
|
||||
|
|
— |
|
|
10,748 |
|
|
— |
|
|
10,748 |
|
||||
|
Gain on lease modification |
— |
|
|
(171) |
|
|
— |
|
|
(171) |
|
||||
|
Stock-based compensation |
239 |
|
|
270 |
|
|
695 |
|
|
1,036 |
|
||||
|
Non-cash lease expense |
124 |
|
|
130 |
|
|
373 |
|
|
386 |
|
||||
|
Retention expense |
18 |
|
|
— |
|
|
494 |
|
|
235 |
|
||||
|
Restructuring and severance costs |
811 |
|
|
— |
|
|
1,287 |
|
|
— |
|
||||
Adjusted EBITDA |
$ |
14,808 |
|
|
$ |
1,640 |
|
|
$ |
29,447 |
|
|
$ |
6,230 |
|
|
|
% sales |
17.2 |
% |
|
2.8 |
% |
|
12.3 |
% |
|
3.1 |
% |
||||
|
|
|
|
|
|
|
|
|
||||||||
Metals Segment |
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ |
11,556 |
|
|
$ |
(11,417) |
|
|
$ |
20,558 |
|
|
$ |
(17,798) |
|
|
Adjustments: |
|
|
|
|
|
|
|
|||||||||
|
Interest expense |
— |
|
|
— |
|
|
— |
|
|
11 |
|
||||
|
Depreciation expense |
1,449 |
|
|
1,387 |
|
|
4,192 |
|
|
4,457 |
|
||||
|
Amortization expense |
680 |
|
|
705 |
|
|
2,041 |
|
|
2,324 |
|
||||
EBITDA |
13,685 |
|
|
(9,325) |
|
|
26,791 |
|
|
(11,006) |
|
|||||
|
Acquisition costs and other |
— |
|
|
— |
|
|
— |
|
|
3 |
|
||||
|
Earn-out adjustments |
160 |
|
|
(146) |
|
|
1,430 |
|
|
(969) |
|
||||
|
Asset impairments |
— |
|
|
— |
|
|
— |
|
|
6,079 |
|
||||
|
|
— |
|
|
10,748 |
|
|
|
|
10,748 |
|
|||||
|
Stock-based compensation |
(7) |
|
|
78 |
|
|
75 |
|
|
249 |
|
||||
|
Retention expense |
18 |
|
|
— |
|
|
494 |
|
|
— |
|
||||
|
Restructuring and severance costs |
313 |
|
|
— |
|
|
363 |
|
|
— |
|
||||
Metals Segment Adjusted EBITDA |
$ |
14,169 |
|
|
$ |
1,355 |
|
|
$ |
29,153 |
|
|
$ |
5,104 |
|
|
|
% segment sales |
20.2 |
% |
|
2.9 |
% |
|
15.1 |
% |
|
3.2 |
% |
||||
|
|
|
|
|
|
|
|
|
||||||||
Specialty Chemicals Segment |
|
|
|
|
|
|
|
|||||||||
Net income (loss) |
$ |
1,360 |
|
|
$ |
1,061 |
|
|
$ |
2,001 |
|
|
$ |
3,521 |
|
|
Adjustments: |
|
|
|
|
|
|
|
|||||||||
|
Interest expense |
— |
|
|
— |
|
|
1 |
|
|
9 |
|
||||
|
Depreciation expense |
389 |
|
|
378 |
|
|
1,165 |
|
|
1,170 |
|
||||
EBITDA |
1,749 |
|
|
1,439 |
|
|
3,167 |
|
|
4,700 |
|
|||||
|
Asset impairments |
— |
|
|
— |
|
|
233 |
|
|
— |
|
||||
|
Stock-based compensation |
5 |
|
|
59 |
|
|
172 |
|
|
178 |
|
||||
|
Restructuring and severance costs |
— |
|
|
— |
|
|
427 |
|
|
— |
|
||||
Specialty Chemicals Segment Adjusted EBITDA |
$ |
1,754 |
|
|
$ |
1,498 |
|
|
$ |
3,999 |
|
|
$ |
4,878 |
|
|
|
% segment sales |
10.9 |
% |
|
12.3 |
% |
|
8.8 |
% |
|
12.1 |
% |
||||
(1) Proxy contest costs and recoveries for the nine months ended
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006316/en/
Company Contact
Chief Financial Officer
1-804-822-3260
Investor Relations
Gateway Investor Relations
1-949-574-3860
SYNL@gatewayir.com
Source:
FAQ
What were Synalloy's Q3 2021 net sales compared to Q2 2021?
How much did Synalloy's net income increase in Q3 2021?
What is the significance of Synalloy's acquisition of DanChem?
How did Synalloy's adjusted EBITDA perform in Q3 2021?
What challenges did Synalloy face in its chemicals segment?
